中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2012年
44期
3134-3136
,共3页
马旭晨%区颂雷%张志泰%胡燕生%宋飞强
馬旭晨%區頌雷%張誌泰%鬍燕生%宋飛彊
마욱신%구송뢰%장지태%호연생%송비강
肺肿瘤%冠状动脉旁路移植术,非体外循环%同期手术
肺腫瘤%冠狀動脈徬路移植術,非體外循環%同期手術
폐종류%관상동맥방로이식술,비체외순배%동기수술
Lung neoplasms%Coronary atrery bypass,off-pump%Combined operations
目的 分析22例行肺切除术同期联合非体外循环冠状动脉旁路移植术(OPCAB)的肺部肿瘤合并严重冠心病患者的病历资料,总结同期手术临床经验.方法 2003年1月至2011年12月,北京安贞医院胸外科共完成同期手术22例,其中男20例,女2例,平均年龄(65±4)岁.临床肿瘤分期大部分为Ⅰ、Ⅱ期,冠状动脉病变程度以两支或三支血管狭窄为主,心肺功能基本正常.正中开胸后先行肺肿瘤活检,OPCAB后根据病理结果行肺局部切除或肺癌根治手术.结果 所有患者安全完成同期肺切除及OPCAB,平均搭桥2.3根.搭桥后11例患者经正中切口完成同期手术(肺癌根治7例,局部切除4例),9例经后外侧切口完成肺癌手术,另2例经后外侧切口完成单支乳内动脉至左前降支搭桥及肺癌根治手术.围手术期无死亡病例及新发心肌梗死情况.平均住院时间(17 ±7)d.平均手术时间(233±41) min.术后18例患者确诊为非小细胞肺癌,4例为良性肿瘤.术后常见并发症:心律失常、肺不张、肺部感染.随访自术后10个月至5年,4例患者因肿瘤复发死亡.结论 同期肺切除术联合OPCAB治疗肺部肿瘤合并冠心病安全、有效.
目的 分析22例行肺切除術同期聯閤非體外循環冠狀動脈徬路移植術(OPCAB)的肺部腫瘤閤併嚴重冠心病患者的病歷資料,總結同期手術臨床經驗.方法 2003年1月至2011年12月,北京安貞醫院胸外科共完成同期手術22例,其中男20例,女2例,平均年齡(65±4)歲.臨床腫瘤分期大部分為Ⅰ、Ⅱ期,冠狀動脈病變程度以兩支或三支血管狹窄為主,心肺功能基本正常.正中開胸後先行肺腫瘤活檢,OPCAB後根據病理結果行肺跼部切除或肺癌根治手術.結果 所有患者安全完成同期肺切除及OPCAB,平均搭橋2.3根.搭橋後11例患者經正中切口完成同期手術(肺癌根治7例,跼部切除4例),9例經後外側切口完成肺癌手術,另2例經後外側切口完成單支乳內動脈至左前降支搭橋及肺癌根治手術.圍手術期無死亡病例及新髮心肌梗死情況.平均住院時間(17 ±7)d.平均手術時間(233±41) min.術後18例患者確診為非小細胞肺癌,4例為良性腫瘤.術後常見併髮癥:心律失常、肺不張、肺部感染.隨訪自術後10箇月至5年,4例患者因腫瘤複髮死亡.結論 同期肺切除術聯閤OPCAB治療肺部腫瘤閤併冠心病安全、有效.
목적 분석22례행폐절제술동기연합비체외순배관상동맥방로이식술(OPCAB)적폐부종류합병엄중관심병환자적병력자료,총결동기수술림상경험.방법 2003년1월지2011년12월,북경안정의원흉외과공완성동기수술22례,기중남20례,녀2례,평균년령(65±4)세.림상종류분기대부분위Ⅰ、Ⅱ기,관상동맥병변정도이량지혹삼지혈관협착위주,심폐공능기본정상.정중개흉후선행폐종류활검,OPCAB후근거병리결과행폐국부절제혹폐암근치수술.결과 소유환자안전완성동기폐절제급OPCAB,평균탑교2.3근.탑교후11례환자경정중절구완성동기수술(폐암근치7례,국부절제4례),9례경후외측절구완성폐암수술,령2례경후외측절구완성단지유내동맥지좌전강지탑교급폐암근치수술.위수술기무사망병례급신발심기경사정황.평균주원시간(17 ±7)d.평균수술시간(233±41) min.술후18례환자학진위비소세포폐암,4례위량성종류.술후상견병발증:심률실상、폐불장、폐부감염.수방자술후10개월지5년,4례환자인종류복발사망.결론 동기폐절제술연합OPCAB치료폐부종류합병관심병안전、유효.
Objective To analyze the outcomes of lung resection and off-pump coronary artery bypass grafting (OPCAB) synchronously for the patients with lung tumor and concurrent coronary heart disease.Methods Twenty-two patients with lung tumor and concurrent coronary heart disease underwent combined surgical interventions between January 2003 and December 2011.They included 20 males and 2 females with a mean age of (65 ± 4) years.The TNM stage of lung cancer was predominantly at stages Ⅰ and Ⅱ.A majority of them had two and three-vessel disease.The tests of cardiothoracic functions were normal.The biopsy of lung tumor was carried out initially through sternotomy approach.Then OPCAB was performed.Finally lung resection was carried out according to the pathological results of lung tumor.Results All patients survived.The average number of anastomosed coronary vessels was 2.3.After myocardial revascularization through a sternotomy approach,the procedures included lobectomy and partial lung resections through sternotomy only (n =11),lobectomy through a lateral thoractomy approach (n =9)and lobectomy and bypass to left anterior descending (LAD) through left thoracotomy only (n =2).Neither death nor new MI occurred during the perioperative period.The mean stay in-hospital was (17 ± 7)days and mean ooperative duration (233 ± 41) min.The diagnoses were non-small cell lung cancer (n =18) and benign tumor (n =4).The most frequent complications were cardiac arrhythmias,atelectasis and pulmonary infections.All of them were followed up for 10-60 months.Within this period,4 patients died from cancer recurrence.Conclusion The combined procedure of OPCABG grafting and pulmonary resection is a safe and effective treatment option for patients with lung cancer and concurrent coronary heart disease.